Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Betaloc ZOK 25 Tablets

Betaloc ZOK 25 Tablets

NAFDAC Reg. No. A4-6203 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 2 November 2026 · synced automatically from official sources.
Producto
Betaloc ZOK 25 Tablets
Número NAFDAC
A4-6203
Principio activo
Metoprolol Tartrate (Metoprolol Succinate)
Dosis
25 mg
Forma
Tablet
Tamaño del envase
1 x 30's
Fabricante
No Constan
Solicitante (titular)
AstraZeneca Nigeria Limited
Approved
30 Apr 2024
Estado
Activo Ver en NAFDAC ↗
Registro válido hasta
1 May 2029
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Metoprolol tartrate: uses, dosage and brands worldwide

Lo que encontramos

  • Betaloc ZOK 25 Tablets is on the NAFDAC register with an active registration (A4-6203). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Betaloc ZOK 25 Tablets

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intravenous metoprolol therapy in patients with definite or suspected acute myocardial infarction in hemodynamically stable patients. ( 1.3 ) 1.1 Hypertension Metoprolol tartrate tablets are indicated for the treatment of hypertension in adult patients, to lower blood pressure. …

Cómo tomarlo y con qué frecuencia
  • Administer once daily with food or after a meal
  • Titrate at weekly or longer intervals as needed and tolerated
  • Hypertension: Recommended starting dosage is 100 mg daily, in single or divided doses
  • Angina Pectoris: Recommended starting dosage is 100 mg daily, given as two divided doses
  • Myocardial Infarction: The starting dosage depends upon tolerance of intravenous metoprolol, see full prescribing information
  • Hypertension Individualize the dosage of metoprolol tartrate tablets
  • Metoprolol tartrate tablets should be taken with or immediately following meals
  • The usual initial dosage is 100 mg daily in single or divided doses
  • Adjust dosage at weekly (or longer) intervals until optimum blood pressure reduction is achieved
  • In general, the maximum effect of any given dosage level will be apparent after 1 week of therapy
  • The effective dosage range of metoprolol tartrate tablets is 100 mg to 450 mg per day
  • Dosages above 450 mg per day have not been studied
  • While once-daily dosing can maintain a reduction in blood pressure throughout the day, lower doses (especially 100 mg) may not maintain a full effect at the end of the 24-hour period
  • Larger or more frequent daily doses may be required
Fortalezas en las que viene

Metoprolol tartrate tablets, USP are supplied as: 25 mg tablet – white round shaped, film coated tablets debossed with ‘C over 73’ on one side and deep break line on other side. 50 mg tablet – pink round shaped, film coated tablets debossed with ‘C over 74’ on one side and deep break line on other side. …

Infancia
  • Safety and effectiveness of metoprolol have not been established
  • In pediatric patients
Older adults

Clinical studies of metoprolol in hypertension did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience in hypertensive patients has not identified differences in responses between elderly and younger patients. …

While you are taking it
  • Advise patients to take metoprolol tartrate tablets regularly and continuously, as directed, preferably with or immediately following meals
  • If a dose is missed, the patient should take only the next scheduled dose (without doubling it)
  • Patients should not interrupt or discontinue metoprolol tartrate tablets without consulting the physician
  • Advise patients to avoid operating automobiles and machinery or engaging in other tasks requiring alertness until the patient’s response to therapy with metoprolol tartrate tablets has been determined; to contact the physician if any difficulty in breathing occurs; to inform the physician or dentist before any type of surgery that he or she …
Talk to a doctor first if

Metoprolol tartrate tablets are contraindicated in severe bradycardia, second- or third-degree heart block, cardiogenic shock, systolic blood pressure

Medicines it may not mix with

Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents. ( 7.1 ) Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction. ( 7.2 ) CYP2D6 Inhibitors are likely to increase metoprolol concentration. ( 7.3 ) Concomitant use of glycosides, clonidine, and diltiazem and verapamil with beta-blockers can increase the risk of bradycardia. ( 7.4 ) Beta-blockers including metoprolol, may exacerbate the rebound hypertension that can follow the withdrawal of clonidine. …

Warnings

Abrupt cessation may exacerbate myocardial ischemia. ( 5.1 ) Heart Failure: Worsening cardiac failure may occur. ( 5.2 ) Bronchospastic Disease: Avoid beta-blockers. ( 5.3 ) Pheochromocytoma: Initiate therapy with an alpha blocker. ( 5.4 ) Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non-cardiac surgery. Do not routinely withdraw chronic beta-blocker therapy prior to surgery. ( 5.5 , 6.1 ) Diabetes: May mask symptoms of hypoglycemia.( 5.6 ) Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm. ( 5.7 ) Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency. …

Posibles efectos secundarios

The following adverse reactions are described elsewhere in labeling: Worsening angina or myocardial infarction [see Warnings and Precautions (5) ] Worsening heart failure [see Warnings and Precautions (5) ]. Worsening AV block [see Contraindications (4) ]. ­Most common adverse reactions: tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, rash. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharma Holdings, Inc. at 1-844-874-7464 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. …

Pregnancy and breastfeeding

8.1 Pregnancy Risk Summary Available data from published observational studies have not demonstrated an association of adverse developmental outcomes with maternal use of metoprolol during pregnancy ( see Data). Untreated hypertension and myocardial infarction during pregnancy can lead to adverse outcomes for the mother and the fetus (see Clinical Considerations). …

If you take too much

Signs and Symptoms - Overdosage of metoprolol may lead to severe bradycardia, hypotension, and cardiogenic shock. Clinical presentation can also include: atrioventricular block, heart failure, bronchospasm, hypoxia, impairment of consciousness/coma, nausea and vomiting. Treatment – Consider treating the patient with intensive care. Patients with myocardial infarction or heart failure may be prone to significant hemodynamic instability. Beta-blocker overdose may result in significant resistance to resuscitation with adrenergic agents, including beta-agonists. …

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-06-10.

Label for metoprolol tartrate (metoprolol succinate), the active ingredient registered with NAFDAC.

Check your pack of Betaloc ZOK 25 Tablets

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Betaloc ZOK 25 Tablets

What is in Betaloc ZOK 25 Tablets?

Betaloc ZOK 25 Tablets contains Metoprolol Tartrate (Metoprolol Succinate) (25 mg), as tablet, according to its NAFDAC registration record.

Is Betaloc ZOK 25 Tablets registered with NAFDAC?

Yes. Betaloc ZOK 25 Tablets is listed on the NAFDAC register under registration number A4-6203, and its registration is active as of 2 November 2026.

Has Betaloc ZOK 25 Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Betaloc ZOK 25 Tablets in our automatically synced alert list.

How can I check that my pack of Betaloc ZOK 25 Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-6203, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Betaloc ZOK 25 Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Administer once daily with food or after a meal. Titrate at weekly or longer intervals as needed and tolerated. ( 2 ) Hypertension: Recommended starting dosage is 100 mg daily, in single or divided doses. ( 2.1 ) Angina Pectoris: Recommended starting dosage is 100 mg daily, given as two divided doses. ( 2.2 ) Myocardial Infarction: The starting dosage depends upon tolerance of …

What is Betaloc ZOK 25 Tablets used for?

Metoprolol tartrate tablets are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Myocardial Infarction, to reduce the risk of cardiovascular mortality when used in conjunction with intra (Summarised from the official U.S. FDA label for metoprolol tartrate (metoprolol succinate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Betaloc ZOK 25 Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.